Trip.com Group (NASDAQ:TCOM) reported quarterly earnings of $0.11 per share which beat the analyst consensus estimate of $(0.03) by 466.67 percent. This is a 37.5 percent increase over earnings of $0.08 per share from the same period last year. The company reported quarterly sales of $730.00 million which beat the analyst consensus estimate of $702.47 million by 3.92 percent. This is a 0.68 percent decrease over sales of $735.00 million the same period last year.
BiomX Announces Dosing Of The First Two Patients In Phase 1b/2a Study Of BX004 For Treatment Of Chronic Respiratory Infections In Patients With Cystic Fibrosis
BiomX Inc. (NYSE:PHGE) (“BiomX” or the “Company”), a clinical-stage microbiome company advancing novel natural and engineered phage therapies that target specific pathogenic bacteria, today
